Explore our materials

Filters

Results (5175)

Margaret Johnson

MD, FRCP

Slideset

HIV

European HIV Clinical Forum 2018

Intergrase inhibitors- What's new?-Margaret Johnson, MD

Slideset

Tokyo Hepatitis Clinical Forum 2019

Evolving Treatment Paradigm and Future Landscape in HCC - Masafumi Ikeda, MD

Slideset

Tokyo Hepatitis Clinical Forum 2019

Current and Future Local Therapies for Early Stage HCC -Shi-Ming Lin, MD

Slideset

Tokyo Hepatitis Clinical Forum 2019

Progress in Hepatitis B Cure Research - Peter Revill, MD, PhD

Slideset

Tokyo Hepatitis Clinical Forum 2019

Immunological Aspects of HBV and HCV Infection - Tatsuya Kanto, MD, PhD

Slideset

Tokyo Hepatitis Clinical Forum 2019

New Anti-HBV Drugs in the Pipeline - Man-Fung Yuen, DSc, MD, PhD

Slideset

Tokyo Hepatitis Clinical Forum 2019

Management of Hepatitis B Reactivation - Yasuhito Tanaka, MD, PhD

Slideset

Tokyo Hepatitis Clinical Forum 2019

Challenges in the Era of Hepatitis C Cure - Naoya Sakamoto, MD

Mark Nelson

MA, MBBS, FRCP

Slideset

Tokyo Hepatitis Clinical Forum 2019

Hepatitis C Management in Special Populations - Mark Nelson, MD

Slideset

Tokyo Hepatitis Clinical Forum 2019

Trend of NAFLD/ NASH in Japan - Katsutoshi Tokushige, MD

Slideset

HIV

Nurses & Pharmacists HIV Clinical Forum 2019

From Diagnosis to Treatment Advisor - Tom Hayes

Slideset

HIV

Nurses & Pharmacists HIV Clinical Forum 2019

Explore our materials

Your Selection Clear All

Topic

Material Type

Intergrase inhibitors- What's new?-Margaret Johnson, MD

Evolving Treatment Paradigm and Future Landscape in HCC - Masafumi Ikeda, MD

Current and Future Local Therapies for Early Stage HCC -Shi-Ming Lin, MD

Progress in Hepatitis B Cure Research - Peter Revill, MD, PhD

Immunological Aspects of HBV and HCV Infection - Tatsuya Kanto, MD, PhD

New Anti-HBV Drugs in the Pipeline - Man-Fung Yuen, DSc, MD, PhD

Management of Hepatitis B Reactivation - Yasuhito Tanaka, MD, PhD

Challenges in the Era of Hepatitis C Cure - Naoya Sakamoto, MD

Hepatitis C Management in Special Populations - Mark Nelson, MD

Trend of NAFLD/ NASH in Japan - Katsutoshi Tokushige, MD

From Diagnosis to Treatment Advisor - Tom Hayes

Switching Patients to New Regimens – The Role of the Pharmacist - William Hickey